Absence of evidence for the efficacy of hydroxychloroquine in systemic sclerosis: Data from case-control monocentric study

Joint Bone Spine. 2023 Mar;90(2):105495. doi: 10.1016/j.jbspin.2022.105495. Epub 2022 Nov 21.
No abstract available

Keywords: Hydroxychloroquine; Systemic sclerosis.

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Case-Control Studies
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic*
  • Scleroderma, Systemic* / drug therapy

Substances

  • Hydroxychloroquine
  • Antirheumatic Agents